No abstract

We present a facile surfactant-free solvothermal method for the fabrication of nearly monodispersed Fe3O4 submicroparticles with tunable particle sizes ranging from 130 to 420 nm by varying the concentration of single iron source FeCl3·6H2O in initial solutions. The morphology and crystal structure of the as-prepared Fe3O4 submicroparticles have been well characterized by using SEM/TEM/HRTEM, XRD, FT-IR, Raman spectroscopy, and XPS methods. It is found that the Fe3O4 particles present single-crystal nature and strong ferromagnetic property with magnetization saturation values ranged in 54.3–88.7 emu·g–1. A complexation–aggregation–phase transformation formation mechanism was first proposed for the nearly monodispersed single-crystal Fe3O4 submicroparticles based upon the quasi-in situ monitoring of the morphology and structure evolution of the samples during the synthesis process. These size-tunable nearly monodispersed Fe3O4 submicroparticles are expected to have promising applications in wide research fields such as bioseparation, targeted drug delivery, and catalysis.

LDH (layered double hydroxides)-based magnetic-sensitive drug−inorganic nanohybrids were assembled by a one-step co-precipitation method. The effect of a magnetic substance on the microstructure and drug release behavior of ibuprofen (IBU)-intercalated Mg−Al−LDH in magnetic nanohybrids was systematically studied via XRD, TEM, XPS, and VSM methods and in vitro release with and without an external magnetic field (MF). The results reveal a well-defined core−shell structure with a gray IBU−LDH shell coated onto the surface of a dark magnetic core and superior magnetic sensitivity of the magnetic nanohybrids. Compared with the clear platelets of the pure IBU−LDH, the IBU−LDH coatings in magnetic nanohybrids exhibit more like a compact stacking film fully covering the magnetic core and their particle sizes and thickness decrease with increasing core contents, explaining an enhanced release rate under no MF. While under a 1500 G MF, the release rate is greatly reduced with increasing core content due to the instant aggregation of the magnetic nanohybrid particles induced by the external MF. The release mechanism was discussed, and a primarily pulsatile drug release upon a consecutive MF “on−off” operation was also achieved.

Nearly monodispersed magnetic Fe(3)O(4)@DFUR-LDH submicro particles containing the anticancer agent DFUR were prepared via a coprecipitation-calcination-reconstruction strategy of LDH materials over the surface of Fe(3)O(4) particles, and present well-defined core-shell structure, strong magnetization and obvious magnetically controlled drug delivery and release properties.

No abstract